Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...

Alterity Therapeutics Limited (ASX:ATH), a pharmaceutical company specializing in the development of therapeutic drugs with a market capitalization of $26.89 million, has filed its quarterly ...

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...

Lawrence A. Kenyon, Executive Vice President, CFO and Interim CEO About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with ...

And that's just what a spacecraft built and operated by Texas-based Firefly Aerospace has set out to do on its 60-day mission to Earth's only natural satellite. Upon arrival, Firefly's spacecraft ...